Trametinib Plus Azacitidine as Bridging Therapy to Hematopoietic Stem Cell Transplantation in an Infant With PTPN11-Mutated Juvenile Myelomonocytic Leukemia.

IF 2.4 3区医学 Q2 HEMATOLOGY

Pediatric Blood & Cancer Pub Date : 2026-10-14 DOI:10.1002/1545-5017.70758

Hisato Segoe, Jutaro Abe, Shinsuke Hirabayashi, Risa Nakashima, Kazumi Oura, Yukayo Terashita, Yuko Cho, Daichi Sajiki, Hideki Muramatsu, Atsushi Manabe

引用次数: 0

查看原文本刊更多论文

曲美替尼加阿扎胞苷作为ptpn11突变的幼年粒细胞白血病婴儿造血干细胞移植的桥接治疗。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Pediatric Blood & Cancer 医学-小儿科

CiteScore

4.90

自引率

9.40%

发文量

546

审稿时长

1.5 months

期刊介绍： Pediatric Blood & Cancer publishes the highest quality manuscripts describing basic and clinical investigations of blood disorders and malignant diseases of childhood including diagnosis, treatment, epidemiology, etiology, biology, and molecular and clinical genetics of these diseases as they affect children, adolescents, and young adults. Pediatric Blood & Cancer will also include studies on such treatment options as hematopoietic stem cell transplantation, immunology, and gene therapy.